Market Summary Follow InVivo Therapeutics Holdings Corp. Continue reading →

An experimental pain treatment tested in mice targets ion channels on sensory nerves, shown above in the human spinal cord. By Kelly ServickMar. Continue reading →

Spinal Fusion Devices Market is valued at USD 6.63 Billion in 2018 and expected to reach USD 9.39 Billion by 2025 with the CAGR of 3.42% over the forecast period. Increasing the number of invasive surgeries related to injuries happened during accident or trauma cases as well as increasing the ageing population around the globe are some important factors driving the growth of spinal fusion devices market. Get Sample Copy of The Report@https://brandessenceresearch.com/requestSample/PostId/1084 **Samplepagesforthisreportare immediatelyaccessibleuponrequest.** Spinal fusion is a neurosurgical ororthopedic surgical techniquethat joins together two or morevertebrae which also known as spondylodesisorspondylosyndesis. Continue reading →

Despite pharmacological treatment, many individuals with multiple sclerosis (MS) continue to experience symptoms and medication side effects. Exercise holds promise for MS, but changes in brain structure following exercise have not been thoroughly investigated, and important cognitive and psychosocial variables are rarely primary outcomes Continue reading →

Berwyn, Pennsylvania--(Newsfile Corp. - March 10, 2021) - Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer's disease (AD), Parkinson's disease (PD) and other neurodegenerative diseases, today announced the Japan Patent Office (JPO) granted the Company's patent (2018-527851) for the treatment or prevention of acute brain or nerve injury by administering ANVS405. Continue reading →

Introduction Rheumatoid arthritis (RA) is a chronic, autoimmune disease that affects about 1% of the global population. It is characterized by synovial joint tissue inflammation and pain, and by potential direct and indirect involvement of other organ systems, such as the cardiovascular, pulmonary, and skeletal systems, and RA is often associated with a significant psychological impact.1,2 The pathogenesis of RA is driven by a complex combination of inflammatory cells and mediators, which are the targets of disease-modifying agents used in the management of RA. Pain is the hallmark symptom of RA and can be debilitating. Continue reading →